RAPT Therapeutics’ $75 Million Common Stock Offering

Cooley advised RAPT Therapeutics, while Davis Polk advised the joint book-running managers in the offering.RAPT Therapeutics, Inc. executed a $75 million SEC-registered follow-on offering of 4,054,055 shares…